Eli Lilly and Company

LLY.NE·Cboe CA·Healthcare
Compare
50.60+0.39 (+0.78%)today
At close: Nov 4, 3:29 PM EST · May be delayed up to 15 min · CAD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close50.21
Open51.11
Day range50.0551.11
52-week range22.8551.11
Off day high−1.00%
Off 52-week high−1.00%
Volume41.74K
Avg. volume (3M)61.81K
Market cap1.74T
EPS (TTM)0.7700
Forward P/E—
P/E ratio (TTM)65.71
Dividend yield0.58% (0.2300)
Beta (5Y)0.37
Shares outstanding32.81B
Short interest0.00% of float
Earnings dateAug 7, 2025
Analyst target—
Profit margin30.99%

Against its peers

Compare in full ›
LLY.NE 0QCV.IL BMY AZN BIIB 0QYQ.IL
Market cap 1.74T 535.73B 131.21B 293.14B 37.61B 215.56B
P/E (TTM) 65.7 61.3 14.2 26.7 110.2 39.8
Forward P/E — — 9.6 16.7 15.6 —
Price/book 1.4 40.9 5.6 5.7 2.0 10.2
Dividend yield 0.58% 4.05% 3.93% 1.69% — 3.81%
1-year change +35.37% +33.33% +32.80% +13.30% +62.24% +38.91%
Today +0.78% +4.86% +4.02% +2.79% +2.22% +0.58%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All LLY.NE news ›
Sports Business Journal·Positive

Excel Sports Management adds key accounts with Deloitte, Eli Lilly

Sports Business Journal Excel Sports Management adds key accounts with Deloitte, Eli Lilly Acclamation should be extended to Excel Sports Management for noteworthy agency of record wins in two recent RFPs. Industry sources tell us E

LLY
Devdiscourse·

Reuters Health News Summary

AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter.…

Seeking Alpha·Positive

Eli Lilly: Higher Volume, Lower Realized Prices

Pharmaceutical company Eli Lilly and Company (LLY) reported volume growth of 53% last quarter against a 15% decline in realized prices. Revenue rose 39%. Gross margin went up year-over-year, too. That combination is unusual Best Stocks Now…

The Motley Fool·Positive

Pharming: 3 Key Takeaways for Long-Term Investors

A rare-disease player with a stabilized core product is now targeting a market 26 times larger, fueled by cash generation that needs no external financing. On its third-quarter 2026 earnings call, held on Oct. 27, 2026, Pharming (PHAR…

From the 4Search news index, newest first.

In the news

1,482mentions in 30 days
362with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance